NCT07231510 Chlordecone Exposure and Female Fertility
| NCT ID | NCT07231510 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de la Guadeloupe |
| Condition | Infertility Female |
| Study Type | OBSERVATIONAL |
| Enrollment | 634 participants |
| Start Date | 2024-01-26 |
| Primary Completion | 2026-01-26 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 634 participants in total. It began in 2024-01-26 with a primary completion date of 2026-01-26.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Chlordecone is an organochlorine pesticide used in the French West Indies (FWI) from 1972 to 1993 to control the banana root borer. Due to its very long persistence the population continues to be exposed to this chemical through their food consumptions. Although, chlordecone have been associated in animal study impairment of ovarian reserve, to date, no study has been published concerning the link between chlordecone exposure and female fertility. The main objective of this project is to study the association between chlordecone exposure and anti-mullerian hormone (AMH) in women consulting for couple infertility in Guadeloupe.
Eligibility Criteria
Inclusion Criteria: * Women aged from 18 to 39 years * Consulting for couple infertility at the Centre Caribéen de Médecine de la Reproduction (CCMR, Caribbean Center for Reproductive Medicine) of the University Hospital of Guadeloupe * Free, informed and written consent Exclusion Criteria: * Women aged from 18 to 39 years * Consulting for couple infertility at the Centre Caribéen de Médecine de la Reproduction (CCMR, Caribbean Center for Reproductive Medicine) of the University Hospital of Guadeloupe * Free, informed and written consent
Contact & Investigator
Ronan Garlantezec, MD PhD
STUDY DIRECTOR
CHU de Rennes - Université de Rennes
Frequently Asked Questions
Who can join the NCT07231510 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 39 Years, studying Infertility Female. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07231510 currently recruiting?
Yes, NCT07231510 is actively recruiting participants. Contact the research team at melanie.petapermal@chu-guadeloupe.fr for enrollment information.
Where is the NCT07231510 trial being conducted?
This trial is being conducted at Pointe-à-Pitre, Guadeloupe.
Who is sponsoring the NCT07231510 clinical trial?
NCT07231510 is sponsored by Centre Hospitalier Universitaire de la Guadeloupe. The principal investigator is Ronan Garlantezec, MD PhD at CHU de Rennes - Université de Rennes. The trial plans to enroll 634 participants.